Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News


NeoStem Closes Divestiture of Its Ownership Interest in Suzhou Erye 

 

NeoStem Closes Divestiture of Its Ownership Interest in Suzhou Erye
NASDAQ
13, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE:NBS) ("NeoStem" or the "Company"), an emerging market leader in the fast growing cell therapy industry, today announced that the Company has completed the divestiture of its 51% ownership interest ...

 

Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
 
Trackback Url  |  Link to this post | Bookmark this post with: